期刊文献+

轻重链沉积病合并轻链淀粉样变性 被引量:1

Light-heavy chain deposition disease with light chain amyloidosis
下载PDF
导出
摘要 中年女性,临床表现为血清肌酐升高,中等量蛋白尿、大量镜下血尿,无高血压,轻度贫血,免疫固定电泳图谱见λ型Ig G单克隆免疫球蛋白条带,骨髓细胞学检查浆细胞比例为8%。肾活检示肾小球系膜区轻-中度增宽,肾血管壁刚果红染色阳性,免疫荧光染色Ig G及λ轻链呈线状沉积于肾小球毛细血管袢及肾小管基膜,间质血管壁λ轻链阳性,超微结构见肾小球基膜内侧缘、系膜区、肾小管基膜外侧缘细沙样高密度的电子致密物沉积,免疫电镜下见电子致密物Ig G、λ轻链染色胶体金颗粒阳性,间质动脉壁淀粉丝分布;皮肤脂肪活检刚果红染色阳性。最终诊断为轻重链沉积病(Ig G-λ型)合并AL型系统性淀粉样变性(累及肾脏、皮肤、心脏)。 A 49-year-old woman presented with renal insufficiency,proteinuria,hematuria and serum monoclonal immunoglobulin Ig G-λ.Bone marrow aspirate revealed 8% plasma cells. Renal biopsy showed mild to moderate mesangial proliferation with positive Congo red staining in the vessels.Immunoflurerscence indicated linear staining along GBMs,TBMs and mesangium for λ light chains and Ig G.Ultrastructral examination showed granular electron dense deposits delineating the outer aspect of the TBMs and the endothelial aspect of the GBMs. The final diagnosis was light-heavy chain deposition disease( Ig G-λ) with light chain amyloidosis,with kidney,skin and heart involved.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2016年第6期573-578,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 淀粉样变性 轻重链沉积病 肾活检 amyloidosis light-heavy chain deposition disease renal biopsy
  • 相关文献

参考文献3

二级参考文献41

  • 1Cohen AD, Comenzo RL. Systemic light-chain amyloidosis : advances in diagnosis, prognosis, and therapy. Hematology Am Soc Hematol Educ Program ,2010,2010:287 - 294.
  • 2Gertz MA, Lacy MQ, Dispenzieri A, et al. Amyloidosis. Best Pract Res Clin Haemato1,2005,18 (4) :709 - 727.
  • 3Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med,2003,349(6) :583 -596.
  • 4Kastritis E, Dimopoulos MA. Prognosis and risk assessment in AL amyloidosis—state of the art. Amyloid ,2011,18 ( Suppl 1 ) : 84 - 86.
  • 5Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation ,2005,112 ( 13 ) :2047 - 2060.
  • 6Palladini G,Campana C, Klersy C, et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction inAL amyloidosis. Circulation ,2003,107 ( 19 ) :2440 - 2445.
  • 7Dispenzieri A, Kyle RA, Gertz MA, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet,2003,361 (9371) :1787 - 1789.
  • 8Merlini G,Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol,2011,29(14) :1924 -1933.
  • 9Bergesio F, Ciciani AM, Manganaro M, et al. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Nephrol Dial Transplant,2008,23 ( 3 ) :941 - 951.
  • 10Katzmann JA, Abraham RS, Dispenzieri A, et al. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem,2005,51 ( 5 ) : 878 - 881.

共引文献33

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部